EyePoint Pharmaceuticals
EYPT
EYPT
36 hedge funds and large institutions have $70.5M invested in EyePoint Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.4% more ownership
Funds ownership: 2.89% → 6.29% (+3.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
29% less call options, than puts
Call options by funds: $79K | Put options by funds: $111K
Holders
36
Holding in Top 10
1
Calls
$79K
Puts
$111K
Top Buyers
| 1 | +$35.1M | |
| 2 | +$5.63M | |
| 3 | +$1.43M | |
| 4 |
JP Morgan Chase
New York
|
+$781K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$590K |
Top Sellers
| 1 | -$622K | |
| 2 | -$143K | |
| 3 | -$134K | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$94K |
| 5 |
VF
Virtu Financial
New York
|
-$48K |